Cost‐effectiveness of the psycho‐educational blended (group and online) intervention HypoAware compared with usual care for people with Type 1 and insulin‐treated Type 2 diabetes with problematic hypoglycaemia: analyses of a cluster‐randomized controlled trial

Publisher： John Wiley & Sons Inc

E-ISSN： 1464-5491|35|2|214-222

ISSN： 0742-3071

Source： DIABETIC MEDICINE, Vol.35, Iss.2, 2018-02, pp. : 214-222

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost‐effectiveness of intensive multifactorial treatment compared with routine care for individuals with screen‐detected Type 2 diabetes: analysis of the ADDITION‐UK cluster‐randomized controlled trial

By  

DIABETIC MEDICINE, Vol. 32, Iss. 7, 2015-07 ,pp. : 907-919

John Wiley & Sons Inc

Access to resources Recommend Favorite

Metformin and β‐cell function in insulin‐treated patients with type 2 diabetes: A randomized placebo‐controlled 4.3‐year trial

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 20, Iss. 3, 2018-03 ,pp. : 730-733

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost‐effectiveness analysis of adding pharmacists to primary care teams to reduce cardiovascular risk in patients with Type 2 diabetes: results from a randomized controlled trial

By  

DIABETIC MEDICINE, Vol. 32, Iss. 7, 2015-07 ,pp. : 899-906

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost-effectiveness of insulin detemir compared to NPH insulin for type 1 and type 2 diabetes mellitus in the Canadian payer setting: modeling analysis*

By Tunis Sandra L.   Minshall Michael E.   Conner Christopher   McCormick John I.   Kapor Jovana   Yale Jean-François   Groleau Danielle  

Current Medical Research and Opinion, Vol. 25, Iss. 5, 2009-05 ,pp. : 1273-1284

Informa Healthcare

Access to resources Recommend Favorite

One‐year sustained glycaemic control and less hypoglycaemia with new insulin glargine 300 U/ml compared with 100 U/ml in people with type 2 diabetes using basal plus meal‐time insulin: the EDITION 1 12‐month randomized trial, including 6‐month extension

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 9, 2015-09 ,pp. : 835-842

John Wiley & Sons Inc

Access to resources Recommend Favorite